Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2017, Vol. 44 Issue (6): 953-955    DOI: 10.12891/ceog3623.2017
Case Report Previous articles | Next articles
A case report of postmenopausal leiomyomatosis peritonealis disseminata
H. Zhou1, †, W. Chen2, †, X. Zhang1, L. Wang1, *()
1 Department of Gynecology, the First Hospital of Jilin University, Changchun, China
2 Department of Orthopedics, China-Japan Union Hospital, Jilin University, Changchun, China
Download:  PDF
Export:  BibTeX | EndNote (RIS)      
Abstract  
Leiomyomatosis peritonealis disseminata (LPD) is a rare and benign disease, mainly occurred in reproductive age. The authors report a postmenopausal Chinese woman with a large, hard, and unmovable mass in lower abdomen. Computerized tomography revealed a mass of 13.4× 12.0 cm with irregular edges adhering to surrounding organs, with multiple nodules around the abdominal aorta, and in the pelvic peritoneum, mesenteric, and ileocecal regions. She had abnormal higher levels of serum carbohydrate antigen (CA) 125, but normal levels of serum CA 19-9, alpha-fetal protein, and carcinoembryonic antigen. After being treated with epirubicin, carboplatin, and interventional embolization, her abdominal mass was reduced by about 10% and she received a successful radical surgery, including pelvic tumor resection, total hysterectomy, bilateral oophorectomy, omental resection, appendectomy, rectal resection, and anastomosis. Her pelvic mass weighed 1,350 grams and histologically diagnosed as LPD. Immunohistochemistry of the mass showed positive staining of vimentin, caldesmon, smooth muscle actin (SMA), b-catenin, and Bcl-2, but negative for CD10, CD34, CD99, CD117, S-100, progesterone receptor, and DOG1 staining. She had no disease recurrence during a year of follow up.
Key words:  Leiomyomatosis peritonealis disseminata      Embolization      Postmenopausal women     
Published:  10 December 2017     
*Corresponding Author(s):  L. WANG     E-mail:  wanglina1973@163.com
About author:  † Co-first authors.

Cite this article: 

H. Zhou, W. Chen, X. Zhang, L. Wang. A case report of postmenopausal leiomyomatosis peritonealis disseminata. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(6): 953-955.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog3623.2017     OR     https://ceog.imrpress.com/EN/Y2017/V44/I6/953

[1] Jun Xiong, Fen Fu, Wei Zhang, Ji Luo, Yuan-Yuan Xu, Lu-Lu Le, Xiao-Ju He. Study on influencing factors and related clinical issues in cesarean scar pregnancy[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(2): 365-371.
[2] Ja Young Kim, Yun Gyu Song, Chang-Woon Kim, Moon Ok Lee. Uterine artery embolization using gelatin sponge particles for symptomatic focal and diffuse adenomyosis[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 59-65.
[3] H.M. Kim, J.Y. Lee, W.J. Seong. Multidetector computed tomography to predict heavy bleeding and need for angiographic embolization in patients with postpartum hemorrhage[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 478-482.
[4] T.-H. Kim, E. S. Lee, H.-H. Lee, J.-M. Kim, Y.-S. Kim, B. Lee. Vaginal health: insights, views, and attitudes (VIVA). Results from a survey in South Korea[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(6): 938-942.
[5] Y. Wang, F.Y. Luo, Y.D. Xia, L. Mei, L. Xie, H.X. Liu. Clinical analysis of 211 cases of cesarean scar pregnancy[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(6): 948-952.
[6] K. Lee, S. Lee, H. N. Lee, H. Lim, I. J. Kim, I. Y. Park, M. J. Kim. Uterine necrosis following selective embolization for postpartum hemorrhage: report of four cases and review of literature[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(6): 1020-1025.
[7] S. Gyroglou, X. Anthoulaki, D. Deuteraiou, A. Chalkidou, B. Manav, G. Galazios, V. Souftas, P. Tsikouras. Amenorrhea incidence among symptomatic premenopausal women with uterine fibroids after uterine artery embolization (UAE). Our experience[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(4): 618-622.
[8] Y. Zheng, G. Niu, H. Zhang, W. Lu, Z. Liu. Estrogen replacement therapy is not a recommended therapy for postmenopausal women with coronary heart disease: a meta-analysis[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(2): 219-226.
[9] O.B. Poli-Neto, P.S. Silva, T. Mangetti Gonçalvez, M.M. Máximo, J.C. Rosa-e-Silva, F.J. Candido-dos-Reis, A.A. Nogueira. Hormone therapy is not associated to pain thresholds in healthy postmenopausal women[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(1): 66-71.
[10] X.W. Sun, X.M. Bai, Q. Chen, J.F. Shen, L. Yang, J.Y. Zhang, X.S. Gu, Q. Yuan, J. Jing, Y. Jin. Preset catheter sheaths for uterine arterial embolization in the cesarean section of pernicious preplacental placenta: its application[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(1): 108-112.
[11] Lin-lin Guan, Hua-li Wang, Lan-zhou Jiao. Treatment of uterine artery pseudoaneurysm by embolization or hysteroscopy combined with laparoscopy: two case reports[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(6): 959-962.
[12] L.E. Prado Correia, B.C. de Almeida, E. Chada Baracat, I. Silva, J.M. Soares Júnior, C.E. Bonduki, M. Abi Haidar. Efficacy and effects of transdermal hormone therapy in postmenopausal women[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(5): 735-740.
[13] A. Ciavattini, N. Clemente, S. Morini, M. Fichetti, G. Delli Carpini, R. Candelari. Conservative treatment of ectopic cervical pregnancy with uterine artery embolization and cervical curettage: a case report[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(3): 456-458.
[14] A. Rebonato, D. Maiettini, S. Gerli, M. Rossi. Interventional radiology in the management of post-partum hemorrhage[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(2): 163-165.
[15] R.C. Drăguşin, M. Șorop-Florea, C. Constantin, Ş. Tudorache, N. Cernea, D.G. Iliescu. Management of uncomplicated interstitial pregnancy with systemic methotrexate and uterine artery embolization. Case report[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(2): 290-291.
No Suggested Reading articles found!